The role of adjuvant chemotherapy in management of stage I pancreatic ductal adenocarcinoma deserves independent high quality research

J Hepatobiliary Pancreat Sci. 2024 May;31(5):e25-e26. doi: 10.1002/jhbp.1409. Epub 2023 Dec 21.

Authors

Shahin Hajibandeh^{1

2}, Shahab Hajibandeh³, Tejinderjit S Athwal¹

Affiliations

¹ Department of Hepatobiliary and Pancreatic Surgery, Royal Stoke University Hospital, University Hospitals of North Midlands NHS Trust, Stoke-on-Trent, UK.
² Department of Hepatobiliary and Pancreatic Surgery, University Hospital Coventry, Coventry, UK.
³ Department of Hepatobiliary and Pancreatic Surgery, University Hospital of Wales, Cardiff, UK.

PMID: 38126263
DOI: 10.1002/jhbp.1409

No abstract available

Publication types

Editorial
Letter

MeSH terms

Carcinoma, Pancreatic Ductal* / drug therapy
Carcinoma, Pancreatic Ductal* / pathology
Carcinoma, Pancreatic Ductal* / therapy
Chemotherapy, Adjuvant
Humans
Neoplasm Staging*
Pancreatic Neoplasms* / drug therapy
Pancreatic Neoplasms* / pathology
Pancreatic Neoplasms* / therapy